CNTB
NASDAQ
$2.20
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.12 (+223.64%)
Market Cap
$152M
Free Cash Flow Yield
-37.80%
Beta (5Y)
0.27
Price Chart
Valuation
Market Cap$152M
Forward P/E0.77
P/S656.66
P/B3.48
Profitability
Total Revenue (TTM)$233K
Gross Profit (TTM)$233K
EBITDA-$66M
Operating Margin-11602%
EPS-$1.12
Financial Health
Free Cash Flow Yield-37.80%
Growth & Risk
Beta (5Y)0.27
Sharpe Ratio0.54